| AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors (NCT00415103) | PETHEMA Foundation | 2006-11-01 |
| Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia (NCT00886496) | Enzon Pharmaceuticals, Inc. | 2006-11-01 |
| Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma (NCT00411086) | M.D. Anderson Cancer Center | 2006-11-01 |
| Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma (NCT00561301) | Cooperative Study Group A for Hematology | 2006-11-01 |
| Combined Haploidentical-Cord Blood Transplantation for Adults and Children (NCT00943800) | University of Chicago | 2006-10-09 |
| Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma (NCT00433433) | European Organisation for Research and Treatment of Cancer - EORTC | 2006-10-01 |
| Cellular Therapy With Cord Blood Cells (NCT00427557) | M.D. Anderson Cancer Center | 2006-10-01 |
| Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma (NCT00274924) | Eastern Cooperative Oncology Group | 2006-09-26 |
| Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms (NCT00217425) | Eastern Cooperative Oncology Group | 2006-09-14 |
| S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00352443) | SWOG Cancer Research Network | 2006-09-01 |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma (NCT00363090) | Toronto Sunnybrook Regional Cancer Centre | 2006-09-01 |
| RTA 744 Injection in Patients With Leptomeningeal Disease (NCT00512460) | M.D. Anderson Cancer Center | 2006-09-01 |
| Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor (NCT00393380) | The Emmes Company, LLC | 2006-09-01 |
| Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma (NCT00392834) | AIDS Malignancy Consortium | 2006-09-01 |
| Nutritional Assessment Intervention to Improve Cancer-Related Fatigue (NCT00507260) | M.D. Anderson Cancer Center | 2006-09-01 |
| Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation (NCT00383994) | M.D. Anderson Cancer Center | 2006-09-01 |
| Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) (NCT00506948) | M.D. Anderson Cancer Center | 2006-09-01 |
| Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma (NCT00389506) | National Institutes of Health Clinical Center (CC) | 2006-09-01 |
| Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma (NCT00509379) | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | 2006-09-01 |
| Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome (NCT00369629) | Northwestern University | 2006-08-28 |
| S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT00376961) | SWOG Cancer Research Network | 2006-08-01 |
| Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) (NCT00364286) | M.D. Anderson Cancer Center | 2006-08-01 |
| Effect of Interactive Tailored Assessment on Patient-provider Communication (NCT00857103) | Oslo University Hospital | 2006-08-01 |
| Molecular Epidemiology of Lymphoma Patients (NCT00488553) | M.D. Anderson Cancer Center | 2006-08-01 |
| A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China (NCT00559065) | National Cancer Institute (NCI) | 2006-07-11 |
| Dalteparin in Preventing DVT in Participants With Cancer (NCT00525057) | M.D. Anderson Cancer Center | 2006-07-07 |
| Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma (NCT00387959) | Memorial Sloan Kettering Cancer Center | 2006-07-01 |
| Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens (NCT00419081) | BioCryst Pharmaceuticals | 2006-07-01 |
| Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657) | Fred Hutchinson Cancer Center | 2006-07-01 |
| Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS (NCT00360438) | M.D. Anderson Cancer Center | 2006-07-01 |
| Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma (NCT00416312) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-07-01 |
| Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma (NCT00334438) | UNC Lineberger Comprehensive Cancer Center | 2006-07-01 |
| Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment (NCT00416351) | Memorial Sloan Kettering Cancer Center | 2006-06-27 |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma (NCT00413075) | Valerio Therapeutics | 2006-06-01 |
| Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies (NCT00476229) | M.D. Anderson Cancer Center | 2006-06-01 |
| ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer (NCT00387608) | National Institutes of Health Clinical Center (CC) | 2006-06-01 |
| Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas (NCT00493467) | M.D. Anderson Cancer Center | 2006-06-01 |
| Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases (NCT00376922) | Wake Forest University Health Sciences | 2006-06-01 |
| Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer (NCT00827099) | Northside Hospital, Inc. | 2006-06-01 |
| Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT00513955) | University Hospital Plymouth NHS Trust | 2006-06-01 |
| Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL (NCT00732498) | University of Arizona | 2006-05-15 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis (NCT00132015) | National Institutes of Health Clinical Center (CC) | 2006-05-01 |
| CDDO to Treat Solid Tumors and Lymphomas (NCT00322140) | National Cancer Institute (NCI) | 2006-05-01 |
| Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00085449) | Alliance for Clinical Trials in Oncology | 2006-05-01 |
| A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma (NCT00359294) | PharmaMar | 2006-05-01 |
| Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma (NCT00369681) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-05-01 |
| A Phase II Study of Nasal NK/T-cell Lymphoma (NCT00292695) | National Health Research Institutes, Taiwan | 2006-05-01 |
| Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer (NCT00387530) | University of California, San Diego | 2006-05-01 |
| Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00324324) | OHSU Knight Cancer Institute | 2006-05-01 |
| Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) (NCT00368082) | Baylor College of Medicine | 2006-04-01 |
| Prevalence of Lymphoma in IBD (NCT00577538) | Indiana University | 2006-04-01 |
| Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas (NCT00493454) | M.D. Anderson Cancer Center | 2006-04-01 |
| T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation (NCT00306332) | Radboud University Medical Center | 2006-03-01 |
| Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma (NCT00388531) | PETHEMA Foundation | 2006-03-01 |
| Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors (NCT00335491) | University of Utah | 2006-03-01 |
| Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (NCT00971763) | University College, London | 2006-03-01 |
| Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab (NCT00238238) | Alliance for Clinical Trials in Oncology | 2006-03-01 |
| Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma (NCT00299182) | M.D. Anderson Cancer Center | 2006-03-01 |
| Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma (NCT00438802) | Mayo Clinic | 2006-03-01 |
| Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant (NCT00281814) | The Cleveland Clinic | 2006-02-01 |
| An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease. (NCT00440817) | Centocor Ortho Biotech Services, L.L.C. | 2006-02-01 |
| Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation (NCT00281801) | Case Comprehensive Cancer Center | 2006-02-01 |
| Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (NCT00294632) | M.D. Anderson Cancer Center | 2006-02-01 |
| Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer (NCT00281879) | OHSU Knight Cancer Institute | 2006-02-01 |
| Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors (NCT00345189) | Biogen | 2006-02-01 |
| Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma (NCT00070291) | Eastern Cooperative Oncology Group | 2006-01-24 |
| Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation (NCT00698685) | University of Arizona | 2006-01-23 |
| Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma (NCT00278408) | German High-Grade Non-Hodgkin's Lymphoma Study Group | 2006-01-02 |
| Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9 (NCT00400907) | German High-Grade Non-Hodgkin's Lymphoma Study Group | 2006-01-01 |
| Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma (NCT00958854) | Cancer Research UK | 2006-01-01 |
| Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer (NCT00661999) | Mayo Clinic | 2006-01-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NCT00974792) | Cancer Research UK | 2006-01-01 |
| Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss (NCT00352846) | M.D. Anderson Cancer Center | 2006-01-01 |
| Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL (NCT01527422) | Fernando Cabanillas | 2006-01-01 |
| SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma (NCT00293488) | Progen Pharmaceuticals | 2006-01-01 |
| Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma (NCT00301821) | Alliance for Clinical Trials in Oncology | 2006-01-01 |
| Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX) (NCT00195897) | Centre Henri Becquerel | 2006-01-01 |
| Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma (NCT00295932) | Memorial Sloan Kettering Cancer Center | 2005-12-13 |
| Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function (NCT00275093) | National Cancer Institute (NCI) | 2005-12-01 |
| Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma (NCT00057954) | Eastern Cooperative Oncology Group | 2005-11-09 |
| Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma (NCT00134082) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-11-01 |
| Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00290004) | Pharmacyclics LLC. | 2005-11-01 |
| Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma (NCT00255801) | Memorial Sloan Kettering Cancer Center | 2005-11-01 |
| Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia (NCT00899119) | Herbert Irving Comprehensive Cancer Center | 2005-11-01 |
| Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases (NCT00276783) | Northwestern University | 2005-11-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease (NCT00719849) | Fred Hutchinson Cancer Center | 2005-11-01 |
| High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT (NCT03130582) | Yang Jun | 2005-11-01 |
| S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma (NCT00107380) | SWOG Cancer Research Network | 2005-11-01 |
| Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma (NCT00278421) | German High-Grade Non-Hodgkin's Lymphoma Study Group | 2005-11-01 |
| Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen (NCT00448357) | UNC Lineberger Comprehensive Cancer Center | 2005-10-01 |
| AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma (NCT00562380) | Amgen | 2005-10-01 |
| Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma (NCT00310167) | University College, London | 2005-10-01 |
| S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma (NCT00233987) | SWOG Cancer Research Network | 2005-10-01 |
| AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00324597) | Jonsson Comprehensive Cancer Center | 2005-10-01 |
| A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone (NCT00234169) | Peter MacCallum Cancer Centre, Australia | 2005-10-01 |
| Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies (NCT00215605) | Exelixis | 2005-09-01 |
| Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma (NCT00248534) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-09-01 |
| Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil (NCT00608517) | Vanderbilt-Ingram Cancer Center | 2005-09-01 |
| Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00244985) | Roswell Park Cancer Institute | 2005-09-01 |
| An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED) (NCT00127101) | Merck Sharp & Dohme LLC | 2005-09-01 |